Ratings by Leerink (Mike Kratky)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/16/2026 | Edwards Lifesciences | EW | Maintain | Market Perform (N/A) |
|
Details | ||
| 6/11/2026 | Procept BioRobotics Corp | PRCT | Downgrade | Market Perform (Outperform) |
29.09 (21.22) |
-27.05% | Details | |
| 6/5/2026 | Stryker | SYK | Maintain | Outperform (N/A) |
|
Details | ||
| 5/28/2026 | Boston Scientific | BSX | Maintain | Outperform (N/A) |
|
Details | ||
| 5/19/2026 | Boston Scientific | BSX | Maintain | Outperform (N/A) |
|
Details | ||
| 4/22/2026 | Intuitive Surgical | ISRG | Maintain | Outperform (N/A) |
|
Details | ||
| 4/21/2026 | Abbott Labs | ABT | Maintain | Market Perform (N/A) |
|
Details | ||
| 4/16/2026 | Abbott Labs | ABT | Maintain | Market Perform (N/A) |
|
Details | ||
| 4/13/2026 | Stryker | SYK | New Coverage | Outperform (N/A) |
339.15 (331.45) |
-2.27% | Details | |
| 4/13/2026 | Zimmer Biomet | ZBH | New Coverage | Market Perform (N/A) |
93.12 (94.08) |
1.03% | Details | |
| 3/10/2026 | Vericel Corporation | VCEL | Maintain | Outperform (N/A) |
|
Details | ||
| 3/10/2026 | Medtronic, Inc. | MDT | Maintain | Outperform (N/A) |
|
Details | ||
| 2/3/2026 | Medtronic, Inc. | MDT | Maintain | Outperform (N/A) |
|
Details | ||
| 2/2/2026 | NeuroPace Inc | NPCE | Maintain | Outperform (N/A) |
|
Details | ||
| 1/30/2026 | Abbott Labs | ABT | Maintain | Market Perform (N/A) |
|
Details | ||
| 1/16/2026 | Penumbra | PEN | Downgrade | Market Perform (Outperform) |
313.43 (318.94) |
1.76% | Details | |
| 1/9/2026 | Penumbra | PEN | Maintain | Outperform (N/A) |
|
Details | ||
| 12/16/2025 | DexCom | DXCM | Maintain | Outperform (N/A) |
|
Details | ||
| 12/12/2025 | AxoGen, Inc. | AXGN | Maintain | Outperform (N/A) |
|
Details | ||
| 11/21/2025 | Insulet Corporation | PODD | Maintain | Outperform (N/A) |
|
Details | ||
| 11/19/2025 | Medtronic, Inc. | MDT | Maintain | Outperform (N/A) |
|
Details | ||
| 11/5/2025 | NeuroPace Inc | NPCE | Maintain | Outperform (N/A) |
|
Details | ||
| 11/5/2025 | Procept BioRobotics Corp | PRCT | Maintain | Outperform (N/A) |
|
Details | ||
| 10/30/2025 | AxoGen, Inc. | AXGN | Maintain | Outperform (N/A) |
|
Details | ||
| 10/23/2025 | Boston Scientific | BSX | Maintain | Outperform (N/A) |
|
Details | ||
| 10/22/2025 | Intuitive Surgical | ISRG | Maintain | Outperform (N/A) |
|
Details | ||
| 10/1/2025 | Boston Scientific | BSX | Maintain | Outperform (N/A) |
|
Details | ||
| 9/9/2025 | Boston Scientific | BSX | Maintain | Outperform (N/A) |
|
Details | ||
| 8/20/2025 | Edwards Lifesciences | EW | Maintain | Market Perform (N/A) |
|
Details | ||
| 8/20/2025 | Medtronic, Inc. | MDT | Maintain | Outperform (N/A) |
|
Details | ||
| 8/19/2025 | Medtronic, Inc. | MDT | Maintain | Outperform (N/A) |
|
Details | ||
| 8/15/2025 | Inspire Medical Systems | INSP | Maintain | Outperform (N/A) |
|
Details | ||
| 8/5/2025 | Inspire Medical Systems | INSP | Maintain | Market Perform (N/A) |
|
Details | ||
| 7/25/2025 | Edwards Lifesciences | EW | Maintain | Market Perform (N/A) |
|
Details | ||
| 7/11/2025 | Medtronic, Inc. | MDT | Maintain | Outperform (N/A) |
|
Details | ||
| 7/2/2025 | Intuitive Surgical | ISRG | Maintain | Outperform (N/A) |
|
Details | ||
| 6/26/2025 | NeuroPace Inc | NPCE | Maintain | Outperform (N/A) |
|
Details | ||
| 6/16/2025 | Boston Scientific | BSX | New Coverage | Outperform (N/A) |
99.74 (44.65) |
-55.23% | Details | |
| 6/16/2025 | Medtronic, Inc. | MDT | New Coverage | Outperform (N/A) |
87.27 (83.57) |
-4.24% | Details | |
| 6/16/2025 | Abbott Labs | ABT | New Coverage | Market Perform (N/A) |
135.62 (92.11) |
-32.08% | Details | |
| 5/27/2025 | NeuroPace Inc | NPCE | Maintain | Outperform (N/A) |
|
Details | ||
| 4/28/2025 | Procept BioRobotics Corp | PRCT | Maintain | Outperform (N/A) |
|
Details | ||
| 4/23/2025 | Intuitive Surgical | ISRG | Maintain | Outperform (N/A) |
|
Details | ||
| 2/27/2025 | Tandem Diabetes Care | TNDM | Maintain | Outperform (N/A) |
|
Details | ||
| 2/25/2025 | AxoGen, Inc. | AXGN | Maintain | Outperform (N/A) |
|
Details | ||
| 2/11/2025 | Inspire Medical Systems | INSP | Maintain | Market Perform (N/A) |
|
Details | ||
| 11/7/2024 | Tandem Diabetes Care | TNDM | Maintain | Outperform (N/A) |
|
Details | ||
| 9/3/2024 | Penumbra | PEN | New Coverage | Outperform (N/A) |
202.32 (313.43) |
54.92% | Details | |
| 9/3/2024 | Inari Medical Inc. | NARI | New Coverage | Market Perform (N/A) |
43.23 (79.97) |
84.99% | Details | |
| 4/17/2024 | Edwards Lifesciences | EW | Maintain | Market Perform (N/A) |
|
Details | ||
| 4/8/2024 | Shockwave Medical | SWAV | Downgrade | Market Perform (Outperform) |
319.99 (334.75) |
4.61% | Details | |
| 1/30/2024 | NeuroPace Inc | NPCE | New Coverage | Outperform (N/A) |
14.75 (17.12) |
16.07% | Details | |
| 1/12/2024 | Axonics Modulation Technologies Inc. | AXNX | Downgrade | Market Perform (Outperform) |
68.85 (70.98) |
3.09% | Details | |
| 10/16/2023 | Intuitive Surgical | ISRG | New Coverage | Outperform (N/A) |
273.15 (407.12) |
49.05% | Details | |
| 10/16/2023 | DexCom | DXCM | New Coverage | Outperform (N/A) |
76.19 (76.35) |
0.21% | Details | |
| 10/16/2023 | Insulet Corporation | PODD | New Coverage | Outperform (N/A) |
132.38 (162.06) |
22.42% | Details | |
| 10/16/2023 | Axonics Modulation Technologies Inc. | AXNX | New Coverage | Outperform (N/A) |
53.00 (70.98) |
33.92% | Details | |
| 10/16/2023 | Procept BioRobotics Corp | PRCT | New Coverage | Outperform (N/A) |
26.94 (29.09) |
7.98% | Details | |
| 10/16/2023 | Edwards Lifesciences | EW | New Coverage | Market Perform (N/A) |
70.78 (91.79) |
29.68% | Details | |
| 10/16/2023 | Vericel Corporation | VCEL | New Coverage | Outperform (N/A) |
31.56 (47.49) |
50.48% | Details | |
| 10/16/2023 | AxoGen, Inc. | AXGN | New Coverage | Outperform (N/A) |
3.98 (39.49) |
892.21% | Details | |
| 10/16/2023 | Inspire Medical Systems | INSP | New Coverage | Market Perform (N/A) |
150.47 (51.36) |
-65.87% | Details | |
| 10/16/2023 | Shockwave Medical | SWAV | New Coverage | Outperform (N/A) |
192.81 (334.75) |
73.62% | Details |
